Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glucuronic Acid SCHEMBL17233397 | 1.00 | PDE4A (0.46) | PDE4ATSHRCYP2C9ALDH1A1TP53 | |
| Glucuronic Acid SCHEMBL12189507 | 1.00 | PDE4A (0.46) | PDE4ATSHRCYP2C9ALDH1A1TP53 | |
| Glucuronic Acid SCHEMBL5974 | 1.00 | PDE4A (0.46) | PDE4ATSHRCYP2C9ALDH1A1TP53 | |
| Glucuronic Acid SCHEMBL6759131 | 1.00 | PDE4A (0.46) | PDE4ATSHRCYP2C9ALDH1A1TP53 | |
| Glucuronic Acid SCHEMBL598674 | 1.00 | PDE4A (0.46) | PDE4ATSHRCYP2C9ALDH1A1TP53 | |
| Mucic Acid SCHEMBL23388836 | 1.00 | PDE4A (0.46) | PDE4ATSHRCYP2C9ALDH1A1TP53 | |
| Glucuronic Acid SCHEMBL23929291 | 1.00 | PDE4A (0.46) | PDE4ATSHRCYP2C9ALDH1A1TP53 | |
| Mucic Acid SCHEMBL23388833 | 1.00 | PDE4A (0.46) | PDE4ATSHRCYP2C9ALDH1A1TP53 | |
| Glucuronic Acid SCHEMBL2559030 | 1.00 | PDE4A (0.46) | PDE4ATSHRCYP2C9ALDH1A1TP53 | |
| Glucuronic Acid SCHEMBL851323 | 1.00 | PDE4A (0.46) | PDE4ATSHRCYP2C9ALDH1A1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4139388-A1 | USE OF HYDROXYCARBOXYLIC ACID SALTS FOR STABILIZING THERMOPLASTIC CONDENSATION POLYMERS, STABILIZED MOULDING COMPOSITIONS AND MOULDING COMPOSITIONS PRODUCED THEREFROM | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2023-03-01 | — | — | EP | claimed |
| WO-2021214207-A1 | USE OF HYDROXYCARBOXYLIC ACID SALTS FOR STABILIZING THERMOPLASTIC CONDENSATION POLYMERS, STABILIZED MOULDING COMPOSITIONS AND MOULDING COMPOSITIONS PRODUCED THEREFROM | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2021-10-28 | — | — | WO | claimed |
| CN-105063125-A | Method for preparing water-soluble polyuronide by virtue of biological polymerization process | UNIV NANJING FORESTRY | 2015-11-18 | — | — | CN | claimed |
| CN-1188134-C | Preparation having increased in vivo tolerability | HOECHST AG (DE) | 2005-02-09 | — | — | CN | claimed |
| CN-1199613-A | Preparation having increased in vivo tolerability | HOECHST AG (DE) | 1998-11-25 | — | — | CN | claimed |
| CN-117801127-A | Houttuynia cordata polysaccharide, preparation method thereof and application of houttuynia cordata polysaccharide in preparation of medicines for treating ulcerative colitis | 中南民族大学 | 2024-04-02 | — | — | CN | disclosed |
| CN-117343207-A | Preparation method and application of Xinjiang fructus oleaster purified polysaccharide | 石河子大学 | 2024-01-05 | — | — | CN | disclosed |
| US-20230190709-A1 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING VAGUS NERVE ASSOCIATED DISEASES, DISORDERS, AND CONDITIONS | MarvelBiome, Inc. (US) | 2023-06-22 | — | — | US | disclosed |
| CN-114409824-B | Mucor exopolysaccharide and preparation method and application thereof | 皖南医学院 | 2022-11-15 | — | — | CN | disclosed |
| CN-114409824-A | Mucor exopolysaccharide and preparation method and application thereof | 皖南医学院 | 2022-04-29 | — | — | CN | disclosed |
| CN-111433176-A | Probes for selective characterization of enzymes involved in xenobiotic metabolism and methods of making and using the same | 巴特尔纪念研究院 | 2020-07-17 | — | — | CN | disclosed |
| CN-106794211-A | Polygalacturonic acid-rhamnogalacturonan (PGRG1) composition | 制药创源有限公司 | 2017-05-31 | — | — | CN | disclosed |
| CN-106459995-A | CRISPR-associated methods and compositions using dominant grnas | 爱迪塔斯医药有限公司 | 2017-02-22 | — | — | CN | disclosed |
| CN-104292364-B | A kind of method extracting bioactive substance from egg shell membrane | 浙江大学 | 2016-08-03 | — | — | CN | disclosed |
| CN-105063125-A | Method for preparing water-soluble polyuronide by virtue of biological polymerization process | UNIV NANJING FORESTRY | 2015-11-18 | — | — | CN | disclosed |
| CN-1188134-C | Preparation having increased in vivo tolerability | HOECHST AG (DE) | 2005-02-09 | — | — | CN | disclosed |
| CN-1199613-A | Preparation having increased in vivo tolerability | HOECHST AG (DE) | 1998-11-25 | — | — | CN | disclosed |